UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549
                                  ------------
                                    FORM 8-K
                                  ------------
                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934

                Date of Report (Date of Earliest Event Reported):
                               September 11, 2003


                           USANA HEALTH SCIENCES, INC.

             (Exact name of registrant as specified in its charter)

                           Commission File No. 0-21116


                  Utah                                   87-0500306
     (State or other jurisdiction of            (IRS Employer Identification
              incorporation)                               Number)


                           3838 West Parkway Boulevard
                           Salt Lake City, Utah 84120
               (Address of principal executive offices, Zip Code)




                                 (801) 954-7100
              (Registrant's telephone number, including area code)




   Former name or former address, if changed since last report: Not Applicable







Item 9.    Regulation FD Disclosure


On September 11, 2003, USANA Health Sciences, Inc., at its international
convention issued a press release regarding plans to open operations in
Singapore in the fourth quarter of 2003. A copy of the press release dated
September 11, 2003 is furnished herewith as Exhibit 99.1 to this Form 8-K and is
incorporated herein by reference.


The information in this Current Report is being furnished and shall not be
deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of that Section.
The information in this Current Report shall not be incorporated by reference
into any registration statement or other document pursuant to the Securities Act
of 1933, as amended. The furnishing of the information in this Current Report is
not intended to, and does not, constitute a representation that such furnishing
is required by Regulation FD or that the information this Current Report
contains is material investor information that is not otherwise publicly
available.

















                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                                  USANA HEALTH SCIENCES, INC.


                                   By: /s/ Gilbert  A. Fuller
                                       ----------------------
                                      Gilbert A. Fuller, Chief Financial Officer

Date: September 11, 2003